| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute pulmonary embolism in COVID-19 related hypercoagulability
|
Lorenzo, Cerruti
|
|
|
50 |
1 |
p. 223-226
|
artikel
|
| 2 |
AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis
|
Xie, Wanmu
|
|
|
50 |
1 |
p. 98-111
|
artikel
|
| 3 |
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation
|
Zhang, Liping
|
|
|
50 |
1 |
p. 20-29
|
artikel
|
| 4 |
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism
|
Reinecke, Isabel
|
|
|
50 |
1 |
p. 12-19
|
artikel
|
| 5 |
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism
|
Solms, Alexander
|
|
|
50 |
1 |
p. 1-11
|
artikel
|
| 6 |
Characterization of circulating thrombin in patients with septic shock: a prospective observational study
|
Becher, Tobias
|
|
|
50 |
1 |
p. 90-97
|
artikel
|
| 7 |
Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin
|
Maurice-Dror, Corinne
|
|
|
50 |
1 |
p. 112-122
|
artikel
|
| 8 |
Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition
|
Dias, Joao D.
|
|
|
50 |
1 |
p. 135-143
|
artikel
|
| 9 |
Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry
|
Kalogeras, Konstantinos
|
|
|
50 |
1 |
p. 82-89
|
artikel
|
| 10 |
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop)
|
Simurda, Tomas
|
|
|
50 |
1 |
p. 233-236
|
artikel
|
| 11 |
Covid-19 treatment update: follow the scientific evidence
|
Becker, Richard C.
|
|
|
50 |
1 |
p. 43-53
|
artikel
|
| 12 |
COVID-19 update: Covid-19-associated coagulopathy
|
Becker, Richard C.
|
|
|
50 |
1 |
p. 54-67
|
artikel
|
| 13 |
Extended duration chemoprophylaxis for venous thromboembolism following abdominopelvic oncologic surgery
|
Kanitra, John
|
|
|
50 |
1 |
p. 190-194
|
artikel
|
| 14 |
Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis
|
Rottenstreich, Amihai
|
|
|
50 |
1 |
p. 151-156
|
artikel
|
| 15 |
Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
|
Roncon, Loris
|
|
|
50 |
1 |
p. 221-222
|
artikel
|
| 16 |
Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol
|
Fuh, L.
|
|
|
50 |
1 |
p. 217-220
|
artikel
|
| 17 |
Left atrial size measured on CT pulmonary angiography: another parameter of pulmonary embolism severity? A systematic review
|
Zuin, Marco
|
|
|
50 |
1 |
p. 181-189
|
artikel
|
| 18 |
Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis
|
Tanaka, Koji
|
|
|
50 |
1 |
p. 174-180
|
artikel
|
| 19 |
Performance of the right ventricular outflow tract/aortic diameter as a novel predictor of risk in patients with acute pulmonary embolism
|
Marginean, Alexandru
|
|
|
50 |
1 |
p. 165-173
|
artikel
|
| 20 |
Pharmacist involvement in clinical assessment and laboratory testing for heparin-induced thrombocytopenia
|
Condon, Amanda J.
|
|
|
50 |
1 |
p. 195-200
|
artikel
|
| 21 |
Reducing state attenuates ectodomain shedding of GPVI while restoring adhesion capacities of stored platelets: evidence addressing the controversy around the effects of redox condition on thrombosis
|
Hosseini, Ehteramolsadat
|
|
|
50 |
1 |
p. 123-134
|
artikel
|
| 22 |
Right ventricular strain in patients with pulmonary embolism and syncope
|
Mohebali, Donya
|
|
|
50 |
1 |
p. 157-164
|
artikel
|
| 23 |
Role of thrombin generation assays in the diagnosis of acute myocarditis and non-ST myocardial infarction
|
Koren, Ofir
|
|
|
50 |
1 |
p. 144-150
|
artikel
|
| 24 |
Should we monitor the direct oral anticoagulants?
|
Diep, Robert
|
|
|
50 |
1 |
p. 30-32
|
artikel
|
| 25 |
Sudden death due to acute pulmonary embolism in a young woman with COVID-19
|
Polat, Veli
|
|
|
50 |
1 |
p. 239-241
|
artikel
|
| 26 |
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
|
Artifoni, Mathieu
|
|
|
50 |
1 |
p. 211-216
|
artikel
|
| 27 |
Thank you to reviewers
|
Becker, Richard C.
|
|
|
50 |
1 |
p. 227-228
|
artikel
|
| 28 |
The risk of intramuscular haematoma is low following injection of benzathine penicillin G in patients receiving concomitant anticoagulant therapy
|
Fox, Emma
|
|
|
50 |
1 |
p. 237-238
|
artikel
|
| 29 |
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
|
Barnes, Geoffrey D.
|
|
|
50 |
1 |
p. 72-81
|
artikel
|
| 30 |
Thromboembolism and bleeding risk in atrial fibrillation ablation with uninterrupted anticoagulation between new oral anticoagulants and vitamin K antagonists: insights from an updated meta-analysis
|
Liu, Xiao-Hua
|
|
|
50 |
1 |
p. 201-210
|
artikel
|
| 31 |
Toward understanding the 2019 Coronavirus and its impact on the heart
|
Becker, Richard C.
|
|
|
50 |
1 |
p. 33-42
|
artikel
|
| 32 |
Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
|
Porfidia, Angelo
|
|
|
50 |
1 |
p. 68-71
|
artikel
|
| 33 |
Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
|
Zhou, Bo
|
|
|
50 |
1 |
p. 229-232
|
artikel
|
Tijdschrift beschrijving